There still is no connection between the price of new drugs and the cost of discovering and developing them, even though the pharmaceutical industry has argued for years that such a link was the primary justification for high prices.
Michelle Obama during her nearly eight years in the White House succeeded in changing the national conversation about diet and exercise, and gave a major boost to transparency about the foods we eat.
The harsh reality of modern-day America is that the less-educated, hourly workforce is falling further and further behind those still clinging to middle class status and above. This is a fairness issue that today characterizes almost every sector of the U.S. economy—including healthcare.
Don't hold your breath waiting for members of Congress to return to Washington to deal with the immediate public health threat posed by the Zika virus. That would require putting the public interest over politics, an approach gone missing in action during this poisonous election year.
Rulemakers in outgoing administrations usually end their tenures with a bang, not a whimper. President Barack Obama's appointees at the CMS are no exception.
A superficial reading of the latest headlines about the health insurance industry suggests it is facing serious problems, but the steady drumbeat of bad news for insurers is showing up everywhere except in the finances of the major carriers.
Last week, two well-respected groups of government economists predicted the end is nigh for the era of restrained growth in healthcare spending. Ignore them. They've been wrong before. They will be proven wrong again.
The CMS continues to adjust its formula for distributing disproportionate-share payments for safety net hospitals based on initial assumptions about insurance coverage under the ACA that have not panned out.
Medicare's first step in reining in the skyrocketing cost of specialty drugs deserves support—something it has not received from hospitals, doctors, politicians or, of course, the pharmaceutical industry, which benefits the most from the status quo.
The horrific events in Orlando in the early hours of June 12 remind us once again of the cowardly failure of our political leaders over many years to take action against America's No. 1 public health crisis.
In the year 2016, we have a major party candidate proclaiming from a public podium that an Indiana-born judge cannot preside fairly over a trial because of his Mexican heritage. This is racism pure and simple.
Obamacare's enemies are gearing up to make rising health insurance premiums a major attack point during the coming election season, but the public needs to consider the real reasons behind the higher prices.